Comparison of Methods to Improve Abdominal Aortic Aneurysm (AAA) Screening Rates in the Primary Care Setting.
NCT ID: NCT01301534
Last Updated: 2013-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1700 participants
OBSERVATIONAL
2010-12-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Nurse initiated Telephone Consult (T-Con) (see attached)
2. Mail-0ut Letter to the patient (see attached)
3. Provider, Nurse and Technician Education with point-of-care patient referrals , Exam Room Flyer
4. Control group (i.e. usual care)
The Provider, Nurse and Technician Education will consist of a presentation given by the Principal Investigator (see attached PowerPoint) to the Family Medicine and Internal Medicine clinic staff and the posting of Exam Room Flyers in each Family Medicine and Internal Medicine exam room to prompt and encourage patient referrals for a AAA screening ultrasound.
Information requested on the attached abstracted data sheet will be used for initial identification of patients that should have a AAA screening ultrasound and again 3-4 months later to see if these same individuals received the procedure. All informational data sets will be totally de-identified by the Research Coordinator, Nellis Air Force Base, prior to releasing to the Principle Investigator.
The data will then be analyzed by Dr. Anneke Bush (WHMC statistician) and the results will be provided to the Principal Investigator for analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T-Con
1\. Nurse initiated Telephone Consult (T-Con)
No interventions assigned to this group
Mail-Out
2\. Mail-0ut Letter to the patient
No interventions assigned to this group
Education
3\. Provider, Nurse and Technician Education with point-of-care patient referrals , Exam Room Flyer
No interventions assigned to this group
Control group
4\. Control group (i.e. usual care)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male patients (DoD beneficiaries) between the ages of 65-75 years old.
Exclusion:
* Female patients.
* Non-English speaking.
* Patients who have already had abdominal CT scan, abdominal MRI, aortography or aortic ultrasound.
* Patients already diagnosed with AAA
65 Years
75 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike O'Callaghan Military Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ethan Zimmerman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Michael O'Callaghan Federal Hospital/Nellis Air Force Base
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael O'Callaghan Federal Hospital/Nellis Air Force Base
Nellis Air Force Base, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20110041H
Identifier Type: -
Identifier Source: org_study_id